A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
Croockewit
A J
AJ
Medizinische Klinik Innsbruck, Austria.
Bronchud
M H
MH
Aapro
M S
MS
Bargetzi
M J
MJ
Crown
J
J
Gratwohl
A
A
Lange
W
W
Ludwig
H
H
Martinelli
G
G
Mertelsmann
R
R
Nuessler
V
V
Willemze
R
R
De Witte
T J
TJ
Zittoun
R
R
Zwierzina
H
H
D000740:Anemia / Q000628:therapy*; D000756:Anemia, Sideroblastic / Q000628:therapy; D004306:Dose-Response Relationship, Immunologic; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D009503:Neutropenia / Q000517:prevention & control
D016298:Hematopoietic Cell Growth Factors; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor